Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8818)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2021 (publication date) through Sep 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Goulart MR, Stasinos K, Fincham REA, Delvecchio FR, Kocher HM. T cells in pancreatic cancer stroma. World J Gastroenterol 2021; 27(46): 7956-7968 [PMID: 35046623 DOI: 10.3748/wjg.v27.i46.7956] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i46/7956.htm |
| Number | Citing Articles |
| 1 |
Matteo Ponzo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, Sylvain Meunier, Fabio Raineri, Allan Thiolat, Rémy Nicolle, Federica Maione, Serena Brundu, Carina Florina Cojocaru, Philippe Bouvet, Corinne Bousquet, Florence Gazeau, Christophe Tournigand, José Courty, Enrico Giraudo, José L. Cohen, Ilaria Cascone. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022; 14(17): 4265 doi: 10.3390/cancers14174265
|
| 2 |
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, Swathi Suresh, Basabi Rana, Ajay Rana. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 113 doi: 10.1016/bs.acr.2023.02.003
|
| 3 |
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines 2024; 12(7): 1596 doi: 10.3390/biomedicines12071596
|
| 4 |
Patrick Schmidt, Johannes Lindemeyer, Pranali Raut, Markus Schütz, Sven Saniternik, Jannika Jönsson, Heike Endepols, Thomas Fischer, Alexander Quaas, Hans Anton Schlößer, Martin Thelen, Holger Grüll. Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats. Cancers 2024; 16(8): 1535 doi: 10.3390/cancers16081535
|
| 5 |
Junzhu Dai, Yuxiang Han, Tianyi Fang, Hongxue Shao, Lei Teng, Huichao Zou. Clinical Significance of Mean Platelet Volume Combined with Neutrophil–Lymphocyte Ratio in Predicting the Therapeutic Effect of Splanchnic Neurolysis. Journal of Inflammation Research 2023; : 5027 doi: 10.2147/JIR.S428641
|
| 6 |
Nabeel Merali, Maria-Danae Jessel, Edward H. Arbe-Barnes, Wing Yu Ruby Lee, Martha Gismondi, Tarak Chouari, James W. O'Brien, Bhavik Patel, Daniel Osei-Bordom, Timothy A. Rockall, Shivan Sivakumar, Nicola Annels, Adam E. Frampton. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma. HPB 2024; 26(7): 873 doi: 10.1016/j.hpb.2024.04.009
|
| 7 |
Mengfei Li, Hongyu Chen, Dingchuan Peng, Xuehan Lu, Jianping Kong, Shujun Luo, Shiqi Li, Chunlu Tan, Ying Wang. FU-coating pH-sensitive liposomes for improving the release of gemcitabine by endosome escape in pancreatic cancer cells. Journal of Drug Delivery Science and Technology 2023; 80: 104135 doi: 10.1016/j.jddst.2022.104135
|
| 8 |
Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Farhad Jadidi-Niaragh, Jamshid Hadjati, Christine E. Brown, Hamid Reza Mirzaei. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1209572
|
| 9 |
Casper W.F. van Eijck, Jie Ju, Freek R. van ’t Land, Maaike Verheij, Yunlei Li, Andrew Stubbs, Michael Doukas, Karishma Lila, Lara R. Heij, Georg Wiltberger, Lola Alonso, Núria Malats, Bas Groot Koerkamp, Eveline E. Vietsch, Casper H.J. van Eijck. The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival. Pancreatology 2024; doi: 10.1016/j.pan.2024.08.014
|
| 10 |
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
|
| 11 |
Dijana Perovic, Marija Dusanovic Pjevic, Vladimir Perovic, Milka Grk, Milica Rasic, Maja Milickovic, Tanja Mijovic, Petar Rasic. B7 homolog 3 in pancreatic cancer. World Journal of Gastroenterology 2024; 30(31): 3654-3667 doi: 10.3748/wjg.v30.i31.3654
Abstract(117) |
Core Tip(108) |
Full Article(HTML)(783)
|
Full Article with Cover (PDF)-2312K(21)
|
Audio-879K(6)
|
Peer-Review Report-207K(9)
|
Answering Reviewers-205K(12)
|
Supplementary Material-418K(16)
|
Full Article (PDF)-1719K(55)
|
Full Article (XML)-258K(14)
|
Times Cited (0)
|
Total Visits (1751)
|
Open
|
| 12 |
Uri Amit, Ugur Uslu, Ioannis I. Verginadis, Michele M. Kim, Seyyedeh Azar Oliaei Motlagh, Eric S. Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J. Atoche, Edgar Ben-Josef, Regina M. Young, Carl H. June, Constantinos Koumenis. Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proceedings of the National Academy of Sciences 2024; 121(31) doi: 10.1073/pnas.2403002121
|
| 13 |
Milica Dimitrijevic Stojanovic, Bojan Stojanovic, Ivan Radosavljevic, Vojin Kovacevic, Ivan Jovanovic, Bojana S. Stojanovic, Nikola Prodanovic, Vesna Stankovic, Miodrag Jocic, Marina Jovanovic. Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential. Biomolecules 2023; 13(10): 1500 doi: 10.3390/biom13101500
|
| 14 |
Shamik Mascharak, Jason L. Guo, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, David M. Lopez, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. Cell Reports Medicine 2023; 4(11): 101248 doi: 10.1016/j.xcrm.2023.101248
|
| 15 |
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana dos Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo. New avenues for the treatment of immunotherapy-resistant pancreatic cancer. World Journal of Gastrointestinal Oncology 2024; 16(4): 1134-1153 doi: 10.4251/wjgo.v16.i4.1134
|
| 16 |
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
|
| 17 |
Sreejith T, Kaladhar Kamalasanan, Sneha S, Pavithran Keechilat, Hani Harb. Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer. ACS Applied Nano Materials 2023; 6(20): 18670 doi: 10.1021/acsanm.3c03454
|
| 18 |
Shichen Zhang, Na Ta, Shihao Zhang, Senhao Li, Xinyu Zhu, Lingyun Kong, Xueqing Gong, Meng Guo, Yanfang Liu. Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set. Cancer Letters 2024; 594: 216981 doi: 10.1016/j.canlet.2024.216981
|
| 19 |
Laura Miró, Júlia López, Pedro E. Guerrero, Neus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, M. Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers 2022; 14(24): 6133 doi: 10.3390/cancers14246133
|
| 20 |
Chien-Yu Chou, Zhi-Qin Li, Hsiao-Chen Huang, Chung-Heng Hung, Shun-Long Weng, Shey-Cherng Tzou. Development of an Albumin-Masked mutPD-1Ig as a Tumor Lesion-Selective Immune Checkpoint Inhibitor. ACS Omega 2023; 8(43): 40911 doi: 10.1021/acsomega.3c06216
|
| 21 |
Ashwin Jainarayanan, Nithishwer Mouroug-Anand, Edward H. Arbe-Barnes, Adam J. Bush, Rachael Bashford-Rogers, Adam Frampton, Lara Heij, Mark Middleton, Michael L. Dustin, Enas Abu-Shah, Shivan Sivakumar. Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells. iScience 2023; 26(4): 106324 doi: 10.1016/j.isci.2023.106324
|
| 22 |
Hang Yu, Wenting Zhu, Caiyan Lin, Menglei Jia, Xiaoxiao Tan, Zhongwen Yuan, Senglin Feng, Pengke Yan. Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancer. Biomaterials Science 2024; 12(1): 116 doi: 10.1039/D3BM01118F
|
| 23 |
Francesca R. Delvecchio, Rachel E.A. Fincham, Sarah Spear, Andrew Clear, Marina Roy-Luzarraga, Frances R. Balkwill, John G. Gribben, Michele Bombardieri, Kairbaan Hodivala-Dilke, Melania Capasso, Hemant M. Kocher. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(5): 1543 doi: 10.1016/j.jcmgh.2021.06.023
|
| 24 |
Jason L. Guo, David M. Lopez, Shamik Mascharak, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. Tissue Engineering Part A 2024; doi: 10.1089/ten.tea.2024.0039
|
| 25 |
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro, Gabriella Mincione. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. Cancers 2023; 15(11): 2923 doi: 10.3390/cancers15112923
|
| 26 |
Ting Yang, Qiao-Qi Li, Yong-Mei Liu, Biao Yang. T cells in pancreatic cancer stroma: Tryptophan metabolism plays an important role in immunoregulation. World Journal of Gastroenterology 2023; 29(17): 2701-2703 doi: 10.3748/wjg.v29.i17.2701
|
| 27 |
Othman Saleh, Hani Shihadeh, Ahmad Yousef, Hana Erekat, Fatima Abdallh, Ahmad Al-leimon, Rawan Elsalhy, Abdalrahman Altiti, Majd Dajani, Majd M. AlBarakat. The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and Treatment. Pancreas 2024; 53(5): e450 doi: 10.1097/MPA.0000000000002342
|
| 28 |
Shreyas Gaikwad, Sanjay K. Srivastava. Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy. Molecular Therapy 2024; 32(9): 3145 doi: 10.1016/j.ymthe.2024.07.029
|
| 29 |
Julia Persky, Sylvia M. Cruz, Morgan A. Darrow, Sean J. Judge, Yueju Li, Richard J. Bold, Anthony N. Karnezis, Karen E. Matsukuma, Lihong Qi, Robert J. Canter. Characterization of natural killer and cytotoxic T‐cell immune infiltrates in pancreatic ductal adenocarcinoma. Journal of Surgical Oncology 2024; 129(5): 885 doi: 10.1002/jso.27581
|
| 30 |
Sawsan Sudqi Said, Wisam Nabeel Ibrahim. Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives. Pharmaceutics 2023; 15(4): 1143 doi: 10.3390/pharmaceutics15041143
|
| 31 |
Jens von den Driesch, Jana Flöttmann, Friedrich Prall, Christina S. Mullins, Michael Linnebacher, Florian Bürtin. HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1082927
|
| 32 |
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Jones A. O. Omoshoro-Jones, Zanele Nsingwane, Ahmed A. A. Hussein, Martin Smith, Geoffrey Candy, Stefano Cacciatore, Pascaline Fru, Ekene Emmanuel Nweke. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12595-x
|
| 33 |
Fotini Poyia, Christiana M. Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences 2024; 25(17): 9555 doi: 10.3390/ijms25179555
|
| 34 |
Angha Naik, Andrew Leask. Tumor-associated fibrosis impairs the response to immunotherapy. Matrix Biology 2023; 119: 125 doi: 10.1016/j.matbio.2023.04.002
|
| 35 |
Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa-Peña, Cindy V. Leiton, Mahmudul Hasan, Sruthi Babu, Danielle Fassler, Jaymie Oentoro, Ji-Dong K Bai, Emanuel F. Petricoin, Lynn M. Matrisian, Edik Matthew Blais, Natalia Marchenko, Felicia D. Allard, Wei Jiang, Brent Larson, Andrew Hendifar, Chao Chen, Shahira Abousamra, Dimitris Samaras, Tahsin Kurc, Joel Saltz, Luisa F. Escobar-Hoyos, Kenneth R. Shroyer. Keratin 17 modulates the immune topography of pancreatic cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05252-1
|
| 36 |
Sajid Khan, Vivekananda Budamagunta, Daohong Zhou. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 145 doi: 10.1016/bs.acr.2023.02.004
|
| 37 |
Dae Ui Lee, Beom Seok Han, Kyung Hee Jung, Soon-Sun Hong. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma. Biomolecules & Therapeutics 2024; 32(3): 281 doi: 10.4062/biomolther.2024.029
|